# Triterpenoids from Acacia ataxacantha DC: antimicrobial and antioxidant activities

Abdou Madjid O. Amoussa, Latifou Lagnika, Mélanie Bourjot, Catherine

Vonthron-Senecheau, Ambaliou Sanni

► To cite this version:

Abdou Madjid O. Amoussa, Latifou Lagnika, Mélanie Bourjot, Catherine Vonthron-Senecheau, Ambaliou Sanni. Triterpenoids from Acacia ataxacantha DC: antimicrobial and antioxidant activities. BMC Complementary and Alternative Medicine, 2016, 16 (1), 10.1186/s12906-016-1266-y. hal-03536465

HAL Id: hal-03536465

https://hal.science/hal-03536465

Submitted on 19 Jan 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
reported the antioxidant, antifungal, antibacterial activities and toxicity of the bark extracts of this plant [7–9]. These results suggests that this plant might contain bioactive compounds that act as antimicrobial and antioxidant agents. It has been reported that in vitro tests do not necessarily confirm that the plant extracts are effective drugs or a suitable candidate for drug development, it provides a basis for understanding the effectiveness of the plant and leads in particular to the search for new active substances [10]. Therefore, the aim of this study was to isolate bioactive compound from *A. ataxacantha* barks and investigate their antimicrobial and antioxidant activities.

# Methods

## Plant material

*Acacia ataxacantha* barks were obtained from Ouidah, department of atlantic, South Bénin. Specimens were authenticated by Dr. Yedomohan, Botanist from National Herbarium of University of Abomey-Calavi. Voucher specimen (AA 6509/ HNB) have been deposited at the same Herbarium. The collected material was dried for four weeks in laboratory (22 °C), grinded into fine powder, and subjected to extraction.

## Extraction and isolation

Dry powdered bark of *A. ataxacantha* (250 g) was successively extracted three times (3 × 500 ml) for 72 h with hexane, dichloromethane, ethyl acetate and methanol by maceration at room temperature. The resulting extracts were filtered, concentrated under reduced pressure, and kept at 4 °C. The dichloromethane extract (2.5 g) was chromatographed by gradient elution on an open column (Silica gel Si 60, 0.063–0.200, mesh) using the mixture n-hexane/EtOAc and EtOAc-MeOH in increasing polarity to yield 36 fractions. These fractions were assembled into four fractions (A, B, C and D) according to the chromatographic profile obtained after thin layer chromatography (TLC) analysis. Fractions A (450 mg) and B (250 mg), soluble in dichloromethane, were recrystallized with methanol. The white precipitates obtained were purified by successive washing with methanol to obtain respectively compound **1** (25 mg) and **2** (32 mg). Purification of fraction C was done using preparative HPLC (Gilson VP 250/21, Nucleodur 100-5 C₁₈ec, Macherey-Nagel, UV detection 220 and 254 nm) with a gradient elution 10:90 to 90:10 (solvent A: H₂O + 0.1 trifluoroacetic acid (TFA), B: AcN + 0.1 TFA) to obtain 7 mg of compound **3**.

## Chemical elucidation of compounds

Structural determination of the isolated compounds was carried out by spectrophotometric methods (1D and 2D NMR, mass and UV spectrometry). 1D (¹H, ¹³C) and 2D (COSY, NOESY, HSQC and HMBC) NMR spectrum

were recorded at room temperature with a Bruker NMR spectrometer (400 MHz and 500 MHz), and mass spectra were recorded using LC-ESI-MS.

## Microbial strains

Bacterial cultures used in this study included *Staphylococcus aureus* (ATCC 6538), *Staphylococcus epidermidis* (CIP 8039), *Enterococcus faecalis* (ATCC 29212), Methicillin-Resistant *Staphylococcus aureus* and *Pseudomonas aeruginosa* (CIP 82118), obtained from Laboratoire de Biophotonique et Pharmacologie, University of Strasbourg, France. *Candida albicans* (CIP 4872) culture used in the present study was obtained from national laboratory of drug control in Cotonou (Bénin). Bacterial were maintained on Mueller-Hinton agar (MHA) and yeast on Sabouraud Dextrose Agar (SDA) at 4 °C. Sub-culturing was done weekly. The cells were inoculated in MH broth for bacteria (37 °C, 18 h) or SD broth for yeast (30 °C, 48 h) prior to the test.

## Bioautography and identification of antimicrobial compounds

This test was performed only on selected bacterial cultures which were remarkably inhibited by dichloromethane and ethyl acetate extracts, according to a modified version of the method of Srinivas et al., [11]. 10 µl of the extracts (20 mg/ml) were applied on a chromatographic plate (Pre-coated TLC-sheets ALUGRAM® silica gel 60 with fluorescent indicator UV₂₅₄; layer thickness 0.20 mm for analytical TLC) followed by elution with a mixture of dichloromethane/methanol (98:2) and dried in air. The plates were run in duplicate. The first plate was used as the reference chromatogram. The spots in the chromatogram were visualized in UV chamber (wavelength 365 and 254 nm) and the plate was sprayed with sulfuric vanillin reagent. Other plates were used for the bioautography. The chromatograms were sprayed with bacterial culture (10⁶ CFU/ml) of *S. aureus*, Methicillin-resistant *S. Aureus*, *S. epidermidis*, *E. faecalis*, *P. aeruginosa* and fungi culture (2 × 10⁵ CFU/ml) of *C. albicans*. Each plate was incubated at (37 °C, 24 h) for bacteria and (30 °C, 48 h) for yeast. The inhibition zones were visualized by spraying the plates with *p*-iodonitrotetrazolium (INT, 2.0 mg/ml).

## Disc diffusion assay

The experiment was performed according to the method described by Qaralleh et al [12] with some modifications. For the determination of antimicrobial activity, cultures were adjusted to 10⁶ CFU/ml for bacteria and 2 × 10⁵ CFU/ml for yeast using 0.5 McFarland standards. Subsequently, cultures were inoculated into MHA for bacteria or SDA for yeast by spreading. The stock solutions of tested compounds were prepared by solubilizing 1 mg of compound in 50 µl of dimethyl
sulfoxide 2.5 % (DMSO 2.5 %). Then, these solutions were diluted in 950 µl of Mueller-Hinton broth for bacteria and Sabouraud broth for yeast strain to obtain 1 mg/ml. The sterile discs of 6 mm of diameter were impregnated with 100 µg (50 µl, 2 mg/ml) of each compound. Discs of gentamicin (30 µg) and fluconazole (25 µg) were used as standard antibacterial and antifungal controls respectively. The plates were incubated at 37 °C, 24 h for bacteria and 30 °C, 48 h for yeast. The diameters of inhibitory zones (including the diameter of the discs) were measured after the incubation period and values superior to 7 mm (D 7 mm) were considered as active against microorganisms. All experiments were performed in triplicate and the antimicrobial activity was expressed as the mean of inhibition zone diameters.

### Minimum inhibitory concentration

The two-fold serial microdilution method was used to determine the minimum inhibitory concentration (MIC) values of isolated compounds against microorganisms [9]. 100 µl of isolated compound (100 µg/ml) and 50 µg/ml of antimicrobial standards (Gentamicin, Fluconazol) were serially diluted two-fold in triplicate with Mueller-Hinton broth for antibacterial test and Sabouraud broth for yeast test in 96-well microplates to make eight concentrations of isolated compound (0.78–100 µg/ml) and standards (0.39–50 µg/ml). 100 µl of fresh culture of bacteria (10⁶ CFU/ml) and yeast (2 × 10⁵ CFU/ml) were added to each well. DMSO (2.5 %) was used as negative control while gentamicin and fluconazole were used as positive controls.

### Minimum bactericidal and fungicidal concentration

The minimum bactericidal (MBC) and minimum fungicidal concentration (MFC) of isolated compounds was determined according to the method of Escalona-Arranz et al [13]. To determine the MBC and MFC, aliquots of 20 µl from all dilutions not showing any growth of bacteria and yeast were inoculated on sterile MHA plates (for bacteria) and SDA (for yeast) by spreading using swab sticks. Inoculated plates were incubated at 37 °C for 24 h for all bacteria, while those with yeast were incubated at 30 °C for 48 h. After incubation, the concentration at which there is no visible growth on the agar plate was recorded as the minimal bactericidal concentration (MBC) and minimal fungicidal concentration (MFC). The experiment was carried out in triplicate.

### Determination of MIC index

The MIC index (MBC/MIC) was calculated for each isolated compound and positive control drug to determine whether a compound had bactericidal/fungicidal

(MBC/MIC ≤4) or bacteriostatic/fungistatic (4 < MBC/MIC <32) effect [14].

### In vitro antioxidant activity

The isolated compounds (2 mg) and quercetin (control) were dissolved in 1 ml of methanol HPLC-grade. Dilutions were performed to obtain a stock solution at 100 µg/ml. The antioxidant activity of isolated compounds on the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) was determined by the method developed by Danielle and Lall [15], with slight modifications. In this method 96-well plates were used. The stock solution (100 µl) of each isolated compound and quercetin was added separately to the wells in the top row. A two-fold serial dilutions was performed to obtain a concentration range from 1.56 to 100 µg/ml. Finally, 200 µl of methanolic solution of 2,2-diphenyl-1-picrylhydrazyl (2%) were introduced in each well. The plates were allowed to develop in the dark for 30 min before the measurement of the absorbance at 517 nm using a Microplate Reader (Rayto-6500). The capability of each compound and the standard to scavenging the free radical was determined as inhibition percentage using the following formula:

$$ \text{Inhibition percentage (I\%)} = \left[ \frac{(A_{\text{Blank}} - A_{\text{sample}})}{A_{\text{Blank}}} \right] \times 100 $$

$A_{\text{Blank}}$ is the absorbance of the control reaction (containing all reagents except the test sample) $A_{\text{sample}}$ is the absorbance of sample/standard.

The concentration of compound reducing 50 % of free radical DPPH (IC₅₀) was determined graphically. The assay was replicated three times and results are expressed as mean ± standard deviation.

### Statistical analysis

All experiments were conducted in triplicate and the results were expressed as means ± standard deviation. The graph was performed using the Graph Pad Prism 6.1 software (Microsoft, USA).

### Results and discussion

#### Phytochemical investigation

The fractionation of the dichloromethane extract of *A. ataxacantha* using silica gel column chromatography led to the isolation of three compounds (1–3) identified as lupeol, betulinic acid and betulinic acid-3-trans-caffeate (Fig. 1).

Compound 1: White powder, ¹H NMR (400 MHz, CDCl₃): δH 0.72 (3H, s, H-24), 0.78 (3H, s, H-28), 0.81 (3H, s, H-25), 0.92 (3H, s, H-27), 0.97 (3H, s, H-23), 1.01 (3H, s, H-26), 1.66 (3H, s, H-30), 3.17 (1H, dd, J = 11Hz, 5 Hz, H-3), 4.55 (1H, dd, J = 2.4Hz, 1.4 Hz, H-29 α), 4.67 (1H, d, J = 2.4Hz, H-29 β). The ¹H
<figure><img src="image_2.png" /><figcaption>**Fig. 1** Isolated triterpenes from *Acacia ataxacantha*. (1): lupeol; (2): Betulinic acid; (3): Betulinic acid-3-trans-caffeate</figcaption></figure>

NMR spectrum of compound 1 revealed the presence of seven tertiary methyl protons at δ 0.72, 0.78, 0.81, 0.92, 0.97, 1.01 and 1.66 (integrated for 3H- each). A sextet of one proton at δ 2.37 assign to 19β-H is characteristic of lupeol. The H-3 proton showed a split doublet at δ 3.17 with a coupling constant of 11 Hz and 5 Hz while, a pair of doublet at δ 4.55 and δ 4.67 (1H, each) was indicative of olefinic protons at (H-29 a & b). Compound 1 was identified as lupeol. All spectral data were in agreement with literature [16–18].

**Compound 2:** White powder, ¹H NMR (400 MHz, CDCl₃): δ<sub>H</sub> 0.65 (3H, s, H-24), 0.76 (3H, s, H-25), 0.86 (3H, s, H-26), 0.93 (3H, s, H-23), 0.97 (3H, s, H-27), 1.65 (3H, s, H-30), 3.32 (1H, m, H-3), 4.56 (1H, s, H-29 α). The ¹H-NMR spectrum of compound 2 exhibited signals for methyl groups at δ 0.65, 0.76, 0.86, and 0.93, 0.97 and 1.65. The ¹H NMR spectrum also displayed signals for olefinic hydrogens at δ 4.69, δ 4.56 (2H, s) for H-29 and hydrogen attached to carbon bearing OH (H-3) at δ 3.32 (1H, s), respectively. The spectral data of compounds 2 were in agreement with previously published data of betulinic acid [19, 20].

**Compound 3:** White amorphous powder. The molecular formula of 3 determined to be C₃₉H₅₄O₆ by positive mode LC-ESI-MS data at m/z 641.38035 [M + Na]⁺ (calcd for C₃₉H₅₄O₆, 641.38035). The UV spectrum exhibited absorption maxima at 245 and 320 nm, suggesting the presence of an aromatic ring

<table><caption>**Table 1** NMR Spectroscopic Data (500 MHz, CDCl₃) of compound 3 (betulinic acid-3-trans-caffeate)</caption><thead><tr><th rowspan="2">Position</th><th colspan="2">Compound 3</th></tr><tr><th>δ<sub>H</sub> (J in Hz)</th><th>δ<sub>C</sub>, type</th></tr></thead><tbody><tr><td>1</td><td>1.73 (m), 1.07 (m)</td><td>39.2, CH<sub>2</sub></td></tr><tr><td>2</td><td>1.68 (m), 1.68 (m)</td><td>24.6, CH<sub>2</sub></td></tr><tr><td>3</td><td>4.57 (t, 5.1)</td><td>81.2, CH</td></tr><tr><td>4</td><td>—</td><td>38.3, C</td></tr><tr><td>5</td><td>0.91 (m)</td><td>55.7, CH</td></tr><tr><td>6</td><td>1.53 (m), 1.46 (m)</td><td>19, CH<sub>2</sub></td></tr><tr><td>7</td><td>1.39 (m), 1.51 (m)</td><td>35.1, CH<sub>2</sub></td></tr><tr><td>8</td><td>—</td><td>42.7, C</td></tr><tr><td>9</td><td>1.43 (m)</td><td>50.7, CH</td></tr><tr><td>10</td><td>—</td><td>34.6, C</td></tr><tr><td>11</td><td>1.12 (m), 1.46 (m)</td><td>21.8, CH<sub>2</sub></td></tr><tr><td>12</td><td>1.26 (m), 1.74 (m)</td><td>26.4, CH<sub>2</sub></td></tr><tr><td>13</td><td>2.39 (m)</td><td>39.0, CH</td></tr><tr><td>14</td><td>—</td><td>43.3, C</td></tr><tr><td>15</td><td>1.59 (m), 1.20 (m)</td><td>30.5, CH<sub>2</sub></td></tr><tr><td>16</td><td>2.26 (m), 1.44 (m)</td><td>32.9, CH<sub>2</sub></td></tr><tr><td>17</td><td>—</td><td>56.8, C</td></tr><tr><td>18</td><td>1.59(m)</td><td>49.5, CH</td></tr><tr><td>19</td><td>3.0(m)</td><td>47.1, CH</td></tr><tr><td>20</td><td>—</td><td>150, C</td></tr><tr><td>21</td><td>1.93 (m), 1.37 (m)</td><td>31.4, CH<sub>2</sub></td></tr><tr><td>22</td><td>1.50 (m), 1.92 (m)</td><td>37.9, CH<sub>2</sub></td></tr><tr><td>23</td><td>0.86 (s)</td><td>28.3, CH<sub>3</sub></td></tr><tr><td>24</td><td>0.89 (s)</td><td>16.3, CH<sub>3</sub></td></tr><tr><td>25</td><td>0.93 (s)</td><td>16.9, CH<sub>3</sub></td></tr><tr><td>26</td><td>0.97 (s)</td><td>16.4, CH<sub>3</sub></td></tr><tr><td>27</td><td>0.97 (s)</td><td>14.9, CH<sub>3</sub></td></tr><tr><td>28</td><td>—</td><td>177.8, C</td></tr><tr><td>29</td><td>4.60, 4.57 (brs)</td><td>110, CH<sub>2</sub></td></tr><tr><td>30</td><td>1.68 (s)</td><td>19.6, CH<sub>3</sub></td></tr><tr><td>1'</td><td>—</td><td>128, C</td></tr><tr><td>2'</td><td>7.07 (d, 1.2)</td><td>122.6, CH</td></tr><tr><td>3'</td><td>—</td><td>115.8, C</td></tr><tr><td>4'</td><td>—</td><td>146.1, C</td></tr><tr><td>5'</td><td>6.86 (d, 8.0)</td><td>143.9, CH</td></tr><tr><td>6'</td><td>6.99 (dd, 8.0, 1.2)</td><td>114.6, CH</td></tr><tr><td>7'</td><td>7.53 (d, 15.9)</td><td>144.3, CH</td></tr><tr><td>8'</td><td>6.24 (d, 15.9)</td><td>116.9, CH</td></tr><tr><td>9'</td><td>—</td><td>167.7, C</td></tr></tbody></table>

Assignments were based on 2D NMR including HSQC, HMBC and NOESY.

Well-resolved couplings are expressed with coupling patterns and coupling constants in hertz in parentheses
in the molecule. ¹H and ¹³C NMR spectral data were resumed in Table 1. The 2D experiments (COSY, NOESY, HSQC and HMBC) were performed using standard Bruker programs.

The compound **3** was inferred to be a triterpene, based on the ¹H NMR spectrum with a broad range of aliphatic signals including six methyl singlets and the ¹³C NMR spectrum with 30 carbons (Table 1). Further investigation of ¹³C NMR spectrum revealed the characteristic signals for carboxylic acid (δC 177.8), vinyl carbons (quaternary C at δC 150.0 and CH₂ at δC 110.0) as well as an oxygen-bearing methine (δC 81.2). This information suggested that the compound **3** is a derivative of betulinic acid bearing an additional aromatic ester moiety at C-3. The aromatic ester was identified as caffeate by ¹H NMR displaying *trans* olefin signal at δ 6.24 (d, *J* = 15.9 Hz). The compound **3** was identified as betulinic acid-3-trans-caffeate, which was confirmed by comparing its data to literature values [21–23].

## Antimicrobial activity

The bioautography technique has been used to identify the bioactive constituents from *A. ataxacantha* extracts. Inhibition zones of antimicrobial components were observed as white spots on a purple red background (Fig. 2). These white areas indicate the presence of antimicrobial compounds which inhibit the growth of microorganisms which did not support the reduction of INT to the coloured formazan [24]. In a previous study, dichloromethane (DCM) extract demonstrated the lowest MIC against *S. aureus*, methicillin-resistant *S. aureus*,

*S. epidermidis*, *E. faecalis* and *P. aeruginosa* [9]. Hence, these bacteria were selected for the bioautography assay to identify antimicrobial compounds. The bioautography assay exhibited inhibition zones (Rf 0.59) for dichloromethane extract against both Gram positive (*S. aureus*, methicillin-resistant *S. aureus*, *S. epidermidis* and *E. faecalis*) and Gram negative (*P. aeruginosa*) (Fig. 2). Interestingly, the bioautogram with *C. albicans* showed inhibition zones at Rf 0.59 (Fig. 3) indicating the same compound was responsible for the antifungal activity against *C. albicans*.

Subsequently, an experiment was conducted to isolate and identify the actives compounds. The isolated compounds were investigated for their antimicrobial activity against Gram-positive (*S. aureus*, methicillin-resistant *S. aureus*, *S. epidermidis* and *E. faecalis*), Gram-negative (*P. aeruginosa*) and yeast (*C. albicans*). The results obtained with disc diffusion assay were presented in Table 2. Only Compound **3** out of the isolated compounds was active against all tested microorganisms (Table 2). The diameter of inhibition of compound **3** ranged from 15.7 to 23.3 mm. The highest inhibitory effect was observed against *S. epidermidis* with inhibition diameter of 23.3 mm. Overall, the Gram-positive bacteria showed a greater susceptibility to compound **3** while *P. aeruginosa* (Gram-negative) showed moderate sensitivity. Compounds **1** and **2** did not inhibit the growth of microorganisms at 100 µg/disc. Previous study showed that compounds **1** and **2** were active against *Escherichia Coli*, *Bacillus Subtilis* and *Staphylococcus aureus* with MIC values ranged from 100 to 200 µg/ml [25]. The negligible antimicrobial activity of compounds **1** and **2** could be explained by the concentration used.

<figure><img src="image_3.png" /><figcaption>**Fig. 2** Bioautography of *A. ataxacantha* extracts. DCM: dichloromethane; AcoEt: Ethyle acetate; *S. aureus*: *Staphylococcus aureus*; *S.am.r*: *Staphylococcus aureus* meticilline resistent; *S. epidermidis*: *Staphylococcus epidermidis*; *E. faecalis*: *Enterococcus feacalis*; *P. aeruginosa*: *Pseudomonas aeruginosa*. White areas indicate where reduction of INT to the coloured formazan did not take place due to the presence of compounds that inhibited the bacterial growth</figcaption></figure>
<figure><img src="image_4.png" /><figcaption>**Fig. 3** Bioautography of *A. ataxacantha* extracts sprayed with *Candida albicans* inoculum. DCM: dichloromethane; AcoEt: Ethyle acetate. White areas indicate where reduction of INT to the coloured formazan did not take place due to the presence of compounds that inhibited the bacterial growth</figcaption></figure>

However, it was reported that betulinic acid was not active against the Gram-positive, Gram-negative bacteria and yeast [26].

The present study has also assessed the quantitative antimicrobial activity of isolated compounds by determining their MIC, MBC and MFC. The results were reported in Table 3. Many reports consider the antimicrobial activities of compounds to be significant if the MIC is 10 µg/ml or lower, moderate if 10 < MIC ≤ 100 µg/ml and low if MIC > 100 µg/ml [27, 28]. Referring to these criteria, the tested compounds had moderate antimicrobial activity with MICs ranged from 12.5 to 50 µg/ml. MBC and MFC values varied between 25 to 50 µg/ml. Only compound 3 showed antimicrobial activity against tested microorganisms at different level. This compound was active against *S. aureus* and *P. aeruginosa* (MIC and MBC were 25 µg/ml in both cases), methicillin-resistant *S. aureus* and *E. faecalis* (MIC or MBC were 50 µg/ml in both cases). The lowest MIC (12.5 µg/ml) of compound 3 was recorded against *S. epidermidis* with a MBC value of 25 µg/ml. Aba et al., also demonstrated the antimicrobial activity of the amyrenol, a triterpene isolated from the roots of *A. ataxacantha* with MIC value of 12 µg/ml and MBC/MFC of 25 µg/ml against *Bacillus subtilis*, *Escherichia coli* and *Salmonella typhi* [29]. Our results and those obtained by Aba et al, demonstrated the importance of triterpenes in the antimicrobial activity of *A. ataxacantha*.

The mechanism of antibiosis of the compound 3 was calculated using MIC index as described by Stefanovic and Comic [14], to elucidate whether the observed antibacterial effect was bactericidal or bacteriostatic. Higher values of MBC and MFC than those of MIC indicates the bacteriostatic or fungistatic nature of the compound 3 against methicillin-resistant *S. aureus*, *S. epidermidis*, *E. faecalis* and *C. albicans*. The same values of MBC and MIC observed against *S. aureus* (50 µg/ml) and *P. aeruginosa* (25 µg/ml) indicated the bactericidal nature of compound 3. MIC and MBC values of compound 3 were most interesting against *P. aeruginosa* which is a Gram-negative bacterium.

<table><caption>**Table 2** Preliminary antimicrobial testing of isolated compounds (1–3) by determination the zone of inhibitory (mm)</caption><thead><tr><th>Bacteria/Fungus</th><th>1 (100 µg.disc<sup>-1</sup>)</th><th>2 (100 µg.disc<sup>-1</sup>)</th><th>3 (100 µg.disc<sup>-1</sup>)</th><th>Gentamicin(30 µg.disc<sup>-1</sup>)</th><th>Fluconazole (25 µg.disc<sup>-1</sup>)</th></tr></thead><tbody><tr><td>S. a</td><td>NA</td><td>NA</td><td>18.3 ± 0.1</td><td>22.5 ± 0.0</td><td>Nt</td></tr><tr><td>S.a.m.r</td><td>NA</td><td>NA</td><td>20.0 ± 0.1</td><td>18.5 ± 0.0</td><td>Nt</td></tr><tr><td>S. ep</td><td>NA</td><td>NA</td><td>23.3 ± 0.0</td><td>20.5 ± 0.0</td><td>Nt</td></tr><tr><td>E. f</td><td>NA</td><td>NA</td><td>21.0 ± 0.1</td><td>22.0 ± 0.0</td><td>Nt</td></tr><tr><td>P. a</td><td>NA</td><td>NA</td><td>15.3 ± 0.0</td><td>14.0 ± 0.1</td><td>Nt</td></tr><tr><td>C. a</td><td>NA</td><td>NA</td><td>15.7 ± 0.0</td><td>NT</td><td>13.7 ± 0.1</td></tr></tbody></table>

Each value is expressed as means (n = 3) ± standard deviation (SD)

S.a : Staphylococcus aureus; Samr: Staphylococcus aureus methicillin resistant; S.ep : Staphylococcus epidermidis; E.f: Enterococcus faecalis; P. a: Pseudomonas aeruginosa; C. a: Candida albicans. 1: lupeol; 2: betulinic acid; 3: betulinic acid-3-trans-caffeate. NA: not actif; NT: not tested
<table><caption>**Table 3** Minimum inhibitory concentration (MIC) and Minimum bactericidal and fungicidal concentrations (MBC, MFC) of compound 3 from *A. ataxacantha*</caption><thead><tr><th rowspan="3">Microorganisms<sup>a</sup></th><th colspan="5">Minimum inhibitory concentrations (µg/ml)</th><th rowspan="3">Yeast<br>C. a</th></tr><tr><th colspan="3">Gram (+) bacteria</th><th rowspan="2">E. f</th><th rowspan="2">P. a</th></tr><tr><th>S. a</th><th>S.a.m.r</th><th>S. ep</th></tr></thead><tbody><tr><td><b>3<sup>b</sup></b></td><td>50</td><td>25</td><td>12.5</td><td>25</td><td>25</td><td>12.5</td></tr><tr><td>Gentamicin</td><td>0.39</td><td>0.39</td><td>0.78</td><td>0.39</td><td>0.78</td><td>Nt</td></tr><tr><td>Fluconazole</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>0.78</td></tr><tr><th colspan="7">Minimum bactericidal and fungicidal (µg/ml)</th></tr><tr><td><b>3<sup>b</sup></b></td><td>50</td><td>50</td><td>50</td><td>50</td><td>25</td><td>25</td></tr><tr><td>Gentamicin</td><td>0.78</td><td>1.56</td><td>1.56</td><td>0.78</td><td>1.56</td><td>Nt</td></tr><tr><td>Fluconazole</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>1.56</td></tr><tr><th colspan="7">MIC index</th></tr><tr><td><b>3<sup>b</sup></b></td><td>1</td><td>2</td><td>4</td><td>2</td><td>1</td><td>2</td></tr><tr><td>Gentamicin</td><td>2</td><td>4</td><td>2</td><td>2</td><td>2</td><td>Nt</td></tr><tr><td>Fluconazole</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>Nt</td><td>2</td></tr></tbody></table>

Several decades ago, the search for antimicrobials was still focused on the discovery of natural compounds able to inhibit Gram-negative bacteria, which are dangerous and causing infectious diseases. The Gram-negative cell wall (made up of lipopolysaccharide) is complex and multilayered structure, which makes access to membrane more restricted and barrier to many environmental substances including synthetic and natural antibiotics [30]. The results of this study indicate that the compound 3, isolated from the bark of *A. ataxacantha*, could be an agent able to cross this complex barrier. In this study, compound 3 (betulinic acid-3-trans-caffeate) is found more active than compound 2 (betulinic acid). This observation is in accordance with the structure-activity relationship as reported previously [20, 31].

<table><caption>**Table 4** Antioxidant activity of compounds (1–3) isolated from *A. ataxacantha*</caption><thead><tr><th>Samples</th><th>IC<sub>50</sub> (µg/ml)</th></tr></thead><tbody><tr><td>Compounds</td><td></td></tr><tr><td>1</td><td>16.77 ± 0.18</td></tr><tr><td>2</td><td>25.15 ± 0.01</td></tr><tr><td>3</td><td>3.57 ± 0.02</td></tr><tr><td>Reference</td><td></td></tr><tr><td>Qercetin</td><td>1.04 ± 0.01</td></tr></tbody></table>

The value of IC₅₀ are expressed as means (n = 3) ± standard deviation (SD)

1: lupeol, 2: betulinic acid, 3: betulinic acid-3-trans-caffeate

## Antioxidant activity

The antioxidant activity of isolated compounds (1–3) were determined using DPPH method and the results are reported in Table 4. Compounds 3 (betulinic acid-3-trans-caffeate) had significant antioxidant activity with an IC₅₀ of 3.57 µg/ml compared to quercetin (control) 1.04 µg/ml. Compound 1 (lupeol) showed moderate activity with an IC₅₀ value of 16.77 µg/ml while compound 2 (betulinic acid) had weak DPPH scavenging activity with an IC₅₀ of 25.15 µg/ml. The antioxidant activity of lupeol was previously reported [32, 33]. The interesting antioxidant activity of compound 3 could be attributed to the phenolic nature of the caffeate substituent. The antioxidant activity of Alkyl caffeates have been also reported [34].

## Conclusion

The results of the present study showed that the betulinic acid-3-trans-caffeate isolated from the bark of *A. ataxacantha* possesses good antimicrobial and antioxidant potency. This compound could be a candidate for structure-activity study in the case of the development of novel antimicrobial agents with an improved therapeutic index. This is the first report on the presence of lupeol, betulinic acid and betulinic acid-3-trans-caffeate in this specie. Further studies are in progress to identify the synergy between the isolated compounds and standard antibiotics.

## Abbreviations

1D, dimensional; 2D, two dimensional; ATCC, American Type Culture Collection; CFU, Colony-forming unit; CIP, collection institute Pasteur; COSY, Correlation Spectroscopy; DCM, dichloromethane; DMSO, Dimethyl sulfoxide; DPPH, 2,2-diphenyl-1-picrylhydrazyl; EtoAc, ethyl acetate; HMBC, Heteronuclear Multiple Bond Correlation; HPLC, High performance liquid chromatography; HSQC, Heteronuclear single quantum coherence spectroscopy; INT, p-iodonitrotetrazolium; MBC, minimum bactericidal concentration; MeOH, methanol; MFC, minimum fungicidal concentration; MHA, Mueller-Hinton agar; MIC, minimum inhibitory concentration; NMR, Nuclear magnetic resonance; NOESY, Nuclear Overhauser Effect Spectroscopy; SDA Sabouraud Dextrose Agar; TFA, trifluoroacetic acid; TLC, thin layer chromatography

## Acknowledgements

We thank the International Foundation for Science (IFS) (Grant F / 5673-1) for supporting equipment and Wood-Wheland fellowship from International Union of Biochemistry and Molecular Biology (IUBMB) for the trip to Strasbourg.

## Funding

This study was granted from International Foundation for Science (IFS) (Grant F/5673-1).

## Availability of data and material

Data are all contained within the paper.

## Authors' contributions

LL designed the study, followed the implementation, participated to isolate compounds, wrote the manuscript, AMA isolated compounds, carried out antimicrobial and antioxidant assay, MB and CVS carried out structural identification of isolated compounds and participated to write the manuscript, AS coordinate the team and helped to revise the manuscript. All authors read and approved the final manuscript.

<footnote><sup>a</sup>S.a: *Staphylococcus aureus*; S.a.m.r: *Staphylococcus aureus* methicillin resistant; S.ep: *Staphylococcus epidermidis*; E.f: *Enterococcus faecalis*; P.a: *Pseudomonas aeruginosa*; C.a: *Candida albicans*</footnote>

<footnote><sup>b</sup>: betulinic acid-3-trans-caffeate</footnote>

<footnote>Nt: not tested. MIC, MBC or MFC of compounds 1 and 2 were not determined</footnote>
**Competing interests**

The authors declare that they have no competing interests.

**Consent for publication**

Not applicable.

**Ethics approval and consent to participate**

Not applicable.

**Author details**

¹Unité de Biochimie et Biologie Moléculaire, Equipe de Biochimie et Substances Naturelles Bioactives, Faculté des Sciences et Techniques, Université d'Abomey-Calavi, Cotonou 04 BP 0320, Bénin. ²Laboratoire d'Innovation Thérapeutique, Faculté de Pharmacie, UMR CNRS-Unistra 7200, Illkirch, France.

Received: 16 January 2016 Accepted: 5 August 2016

Published online: 12 August 2016

**References**

1. Lalitha P, Sripathi SK, Jayanthi P. Acute toxicity study of extracts of *Eichhornia Crassipes* (Mart.) Solms. Asian J Pharm Clin Res. 2012;5(4):59–61.

2. Adamu M, Naidoo V, Eloff JN. Some southern African plant species used to treat helminth infections in ethnoveterinary medicine have excellent antifungal activities. BMC Complement Altern Med. 2012;12:213.

3. Singh BN, Singh BR, Singh RI, Prakesh D, Dhakarey R, Upadhyay G, et al. Oxidative DNA Damage protective activity, antioxidant and antiquorum sensing potentiels of *Moringa oleifera*. Food Chem Toxicol. 2009;47:1109–16.

4. Adjanohoun I, Ahyi M, Aké A, Akouegninou A, Dalmeida J, Akpovo F, Bouke FK, et al. Contribution aux études ethnobotaniques et floristiques en République Populaire du Bénin. Paris: ACCA; 1989. p. 852.

5. MacDonald I, Joseph OE, Harriet ME. Documentation of medicinal plants sold in markets in Abeokuta, Nigeria. Trop J Pharm Res. 2010;9(2):110–8.

6. Kereru PG, Kenji GM, Gachanga AN, Keriko JM, Mungai G. Traditional medicines among EMBU and Mbeere people of Kenya. Afr J CAM. 2007;4(1):75–86.

7. Amoussa AMO, Sanni A, Lagnika L. Antioxidant activity and total phenolic, flavonoid and flavonol contents of the bark extracts of *Acacia ataxacantha*. J Pharmacogn Phytochem. 2015;4(2):172–8.

8. Amoussa AMO, Tchatchedre M, Laleye A, Sanni A, Lagnika L. Acute toxicity and antifungal effects of *Acacia ataxacantha* (Bark). Int J Pharmacogn Phytochem Res. 2015;7(4):661–8.

9. Amoussa AMO, Lagnika L, Sanni A. *Acacia ataxacantha* (bark): chemical composition and antibacterial activity of the extracts. Int J Pharm Pharm Sci. 2014;6(11):138–41.

10. Olajuyigbe OO, Afolayan AJ. In vitro antibacterial and time-kill evaluation of the Erythrina caffra Thunb. extract against bacteria associated with diarrhoea. Sci World J. 2012;2012:8. doi:10.1100/2012/738314.

11. Srinivas P, Rajashekar V, Upender RE, Venkateshwarulu L, Anil KCH. Phytochemical screening and in vitro antimicrobial investigation of the methanolic extract of *Xanthium strumarium* leaf. Int J Drug Dev Res. 2011;3:286–93.

12. Qaralleh HN, Abboud MM, Khleifat KM, Tarawneh KA, Althunibat OY. Antibacterial activity in vitro of *Thymus capitatus* from Jordan. Pak J Pharm Sci. 2009;22(3):247–51.

13. Escalona-Arranz JC, Péres-Roses R, Urdaneta-Laffita I, Camacho-Pozo MI, Rodríguez-Arnado J, Licea-Jiménez I. Antimicrobial activity of extracts from *Tamarindus indica* L. leave. Pharmacogn Mag. 2010;6(23):242–7.

14. Stefanovic O, Comic L. Inhibitory effect of *Cytisus nigricans* L. and *Cytisus capitatus* scop on growth of bacteria. Afr J Microbiol Res. 2011;5:4725–30.

15. Danielle B, Lall N. Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell Line. Evid Based Complement and Alternat Med. 2012;2012:1–11.

16. Moradkhani S, Kobarfard F, Ayatollahi SAM. Phytochemical investigation on chemical constituents of *Achillea tenuifolia* Lam. Iran J Pharm Res. 2014; 13(3):1049–54.

17. Abdullahi SM, Musa AM, Abdullahi M, Sule MI, Sani YM. Isolation of lupeol from the Stem-bark of *Lonchocarpus sericeus* (Papilionaceae). Scholars Acad J Biosci. 2013;1(1):18–9.

18. Jain PS, Bari SB. Isolation of lupeol, stigmasterol and campesterol from petroleum ether extract of woody stem of *Wrightia tinctoria*. Asian J Plant Sci. 2010;9(3):163–7.

19. Getahun T, Reneela P, Aman D. Isolation and characterization of natural products from *Helinus mystachnus* (Rhamnaceae). J Chem Pharm Res. 2012; 4(3):1756–62.

20. Mutai C, Bii C, Vagias C, Abatis D, Roussis V. Antimicrobial activity of *Acacia mellifera* extracts and lupane triterpenes. J Ethnopharmacol. 2009;123:143–8.

21. Kim KH, Choi SU, Lee KR. Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana. Bioorg Med Chem Lett. 2010;20(20):1944–7.

22. Hee KJ, Byun JC, Bandi AKR, Hyun C-G, Lee H. Compounds with elastase inhibition and free radical scavenging activities from *Callistemon lanceolatus*. J Med Plants Res. 2009;3(11):914–20.

23. Pan H, Lundgren LN, Anderson R. Triterpene caffeates from bark of *Betula pubescens*. Phytochemistry. 1994;37:795–9.

24. Eloff JN, Masoko P. The diversity of antifungal compounds of six South African *Terminalia* species (Combretaceae) determined by bioautography. Afr J Biotechnol. 2005;4:1425–31.

25. Ghosh P, Mandal A, Chakraborty P, Rasul MG, Chakraborty M, Saha A. Triterpenoids from *Psidium guajava* with Biocidal Activity. Indian J Pharm Sci. 2010;72(4):504–7. doi:10.4103/0250-474X.73936.

26. Braca A, Morelli I, Mendez J, Battinelli L, Braghiroli L, Mazzanti G. Antimicrobial Triterpenoids from *Licania heteromorpha*. Planta Med. 2000; 66(8):768–9. doi:10.1055/s-2000-9601.

27. Kuete V. Potential of Cameroonian plants and derived products against microbial infections: A review. Planta Med. 2010;76:1479–91.

28. Ndjateu FST, Tsafack RBN, Nganou BK, Awouafack MD, Wabo HK, Tene M, et al. Antimicrobial and antioxidant activities of extracts and ten compounds from three Cameroonian medicinal plants: *Dissotis perskinsiae* (Melastomaceae), *Adenocarpus mannii* (Fabaceae) and *Barteria fistulosa* (Passifloraceae). S Afr J Bot. 2014;91:37–42.

29. Aba OY, Ezuruike IT, Ayo RG, Habila JD, Ndukwu GI. Isolation, antibacterial and antifungal evaluation of α-amyrenol from the root extract of *Acacia ataxacantha* DC. Sch Acad J Pharm. 2015;4(2):124–31.

30. Rakholiya K, Vaghela P, Rathod T, Chanda S. Comparative study of hydroalcoholic extracts of *Momordica charantia* L. against foodborne pathogens. Indian J Pharm Sci. 2014;76(2):148–56.

31. Burger MCM, Terezan AP, Cunha GSO, Fernandes JB, da Silva MFGF, Vieira PC, Menezes ACS. Antimicrobial activity of the myrsinoic acid A from *Myrsine coriacea* and the semi-synthetic derivatives. Rev Bras Farmacogn. 2015;25:451–4.

32. Santiago LA, Mayor ABR. Lupeol: An antioxidant triterpene in *Ficus pseudopalma* Blanco (Moraceae). Asian Pac J Trop Biomed. 2014;4(2):109–18. doi:10.1016/S2221-1691(14)60218-5.

33. Shirwaikar A, Setty MM, Bommu P, Krishnanand B. Effect of lupeol isolated from *Crataeva nurvala* Buch.-Ham. stem bark extract against free radical induced nephrotoxicity in rats. Indian J Exp Biol. 2004;42:686–90.

34. Wang J, Gu H-S, Pang N, Wang F-Q, Pang F, Cui H-S, et al. Alkyl Caffeates improve the antioxidant activity, antitumor property and oxidation stability of edible oil. PLoS ONE. 2014;9(4):e95909.

Submit your next manuscript to BioMed Central and we will help you at every step:

* We accept pre-submission inquiries

* Our selector tool helps you to find the most relevant journal

* We provide round the clock customer support

* Convenient online submission

* Thorough peer review

* Inclusion in PubMed and all major indexing services

* Maximum visibility for your research

Submit your manuscript at
www.biomedcentral.com/submit

BioMed Central